Drs. Crawford and Hou provide an important clinical introduction to a novel class of hormonal agents that have been under development for several decades for the treatment of advanced and metastatic prostate cancer.
Marc B. Garnick, MD
Advertisement
Articles by Marc B. Garnick, MD
Advertisement
Latest Updated Articles
- Important Considerations in LHRH Antagonist Therapy for Prostate Cancer
Published: June 9th 2009 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC
2
How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research
3
Chlorotoxin-Directed Cell Therapy May Have Useful Mechanism in Glioblastoma
4
Ezabenlimab Combo Yields Activity in Advanced Squamous Cell Anal Carcinoma
5
